Premarket Roundup: Merck, First Horizon

NEW YORK (AP) An analyst cut a price target on Merck & Co. Tuesday, the day after the Food & Drug Administration rejected an experimental drug that would have boosted the company's cholesterol franchise.

NEW YORK (AP) An analyst upgraded First Horizon National Corp. late Monday after the regional bank said it would raise $600 million in a stock offering to help boost capital levels.

NEW YORK (AP) A Citi Investment Research analyst began covering hospital operator stocks with "Sell" ratings Tuesday, citing declining patient commercial admissions and growing debt.

NEW YORK (AP) An analyst downgraded shares of Wm. Wrigley Jr. Co. after the announcement that candy company Mars Inc. would buy the iconic gum maker, saying shares are fast approaching the $80 per share purchase price.